Compare CZWI & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CZWI | FENC |
|---|---|---|
| Founded | 1938 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 197.5M | 230.8M |
| IPO Year | 2006 | 2010 |
| Metric | CZWI | FENC |
|---|---|---|
| Price | $22.90 | $10.30 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $14.50 |
| AVG Volume (30 Days) | 99.5K | ★ 281.8K |
| Earning Date | 04-27-2026 | 05-12-2026 |
| Dividend Yield | ★ 2.02% | N/A |
| EPS Growth | ★ 8.96 | N/A |
| EPS | ★ 0.39 | 0.01 |
| Revenue | N/A | ★ $44,642,000.00 |
| Revenue This Year | $13.02 | $65.12 |
| Revenue Next Year | $9.42 | $41.08 |
| P/E Ratio | ★ $56.74 | $953.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.63 | $5.65 |
| 52 Week High | $22.62 | $10.45 |
| Indicator | CZWI | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 70.56 | 71.07 |
| Support Level | $20.10 | $7.40 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.82 | 0.53 |
| MACD | 0.20 | 0.01 |
| Stochastic Oscillator | 96.69 | 92.01 |
Citizens Community Bancorp Inc is a bank holding company that offers traditional community banking services to businesses, Agricultural operators, and consumers, including one-to-four-family residential mortgages. it also offers a variety of loan products including commercial real estate loans, commercial and industrial (C&I) loans, agricultural real estate loans, agricultural operating loans, residential mortgages, home equity lines-of-credit, and consumer loans and offers deposit products through its branches, including demand deposits, various savings and money-market accounts and certificates of deposit. The company's sources of funds are deposits; amortization, prepayments, and maturities of outstanding loans; other short - term investments; and funds provided from operations.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.